Intraoperative anti-thymocyte globulin-fresenius bolus induction therapy in kidney transplantation.
Abou-Jaoude
M M
MM
St-George Hospital, Beirut, Lebanon.
Ghantous
I
I
Najm
R
R
Afif
C
C
Almawi
W Y
WY
D000293:Adolescent; D000328:Adult; D000368:Aged; D000740:Anemia; D000961:Antilymphocyte Serum / Q000009:adverse effects / Q000627:therapeutic use*; D001803:Blood Transfusion; D000075202:Contraindications; D005260:Female; D005334:Fever / Q000139:chemically induced; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D007430:Intraoperative Care / Q000379:methods*; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D010298:Parity; D011184:Postoperative Period; D013921:Thrombocytopenia; D016896:Treatment Outcome
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents